Index S&P 500
P/E 29.97
EPS (ttm) 3.16
Insider Own 0.10%
Shs Outstand 821.41M
Perf Week 0.78%
Market Cap 77.63B
Forward P/E 24.66
EPS next Y 3.84
Insider Trans -32.94%
Shs Float 819.58M
Perf Month 0.10%
Income 2.61B
PEG 3.55
EPS next Q 0.87
Inst Own 86.60%
Short Float 0.91%
Perf Quarter 6.98%
Sales 19.75B
P/S 3.93
EPS this Y 9.02%
Inst Trans -0.61%
Short Ratio 1.81
Perf Half Y 19.18%
Book/sh 0.28
P/B 337.52
EPS next Y 8.97%
ROA 15.95%
Short Interest 7.43M
Perf Year 25.46%
Cash/sh 1.60
P/C 59.26
EPS next 5Y 8.44%
ROE 2331.25%
52W Range 67.62 - 95.59
Perf YTD 18.71%
Dividend Est. 2.01 (2.13%)
P/FCF 25.68
EPS past 5Y 0.18%
ROI 31.15%
52W High -1.01%
Beta 0.38
Dividend TTM 1.94 (2.05%)
Quick Ratio 0.70
Sales past 5Y 4.62%
Gross Margin 59.00%
52W Low 39.93%
ATR (14) 1.13
Dividend Ex-Date Jul 19, 2024
Current Ratio 1.06
EPS Y/Y TTM 65.39%
Oper. Margin 22.28%
RSI (14) 59.60
Volatility 1.16% 1.15%
Employees 34000
Debt/Eq 37.78
Sales Y/Y TTM 7.71%
Profit Margin 13.22%
Recom 1.83
Target Price 98.52
Option/Short Yes / Yes
LT Debt/Eq 35.44
EPS Q/Q 85.18%
Payout 68.86%
Rel Volume 0.65
Prev Close 94.76
Sales Surprise 2.12%
EPS Surprise 5.81%
Sales Q/Q 6.18%
Earnings Apr 26 BMO
Avg Volume 4.11M
Price 94.62
SMA20 1.16%
SMA50 3.47%
SMA200 15.25%
Trades
Volume 2,722,828
Change -0.15%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-01-24 Resumed
Goldman
Buy
$93
Jan-29-24 Upgrade
Raymond James
Mkt Perform → Outperform
Dec-15-23 Upgrade
BofA Securities
Neutral → Buy
$90
Nov-13-23 Initiated
Jefferies
Buy
$87
Oct-16-23 Upgrade
Stifel
Hold → Buy
$85 → $81
Sep-22-23 Initiated
HSBC Securities
Buy
$84
Feb-17-23 Initiated
Citigroup
Buy
$84
Jan-30-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$82
Nov-22-22 Initiated
Wolfe Research
Peer Perform
Oct-13-22 Upgrade
JP Morgan
Neutral → Overweight
$79
Aug-01-22 Upgrade
Wells Fargo
Underweight → Equal Weight
$71 → $80
May-03-22 Downgrade
Atlantic Equities
Overweight → Neutral
$92 → $80
Apr-08-22 Initiated
Raymond James
Mkt Perform
Feb-02-22 Upgrade
Bernstein
Underperform → Mkt Perform
$83
Jan-31-22 Reiterated
Wells Fargo
Underweight
$78 → $76
Jan-31-22 Reiterated
Morgan Stanley
Equal-Weight
$90 → $91
Jan-31-22 Reiterated
Deutsche Bank
Buy
$91 → $90
Jan-31-22 Reiterated
Credit Suisse
Outperform
$95 → $90
Jan-31-22 Reiterated
Citigroup
Neutral
$83 → $86
Dec-16-21 Initiated
Redburn
Neutral
Show Previous Ratings
Jun-14-24 10:42AM
Jun-13-24 04:35PM
01:19PM
11:06AM
Jun-12-24 12:01PM
10:47AM
Loading…
10:47AM
Jun-11-24 11:06AM
Jun-10-24 03:51PM
10:27AM
08:00AM
Jun-07-24 01:40PM
09:28AM
Jun-06-24 10:37AM
09:50AM
Jun-05-24 12:56PM
10:31AM
Loading…
10:31AM
Jun-04-24 10:20AM
Jun-03-24 12:45PM
11:11AM
09:30AM
06:00AM
May-31-24 04:56PM
12:21PM
May-30-24 10:48AM
May-29-24 11:35AM
May-28-24 10:28AM
04:08AM
May-26-24 05:13PM
May-24-24 11:19AM
May-23-24 11:35AM
12:19PM
Loading…
May-22-24 12:19PM
11:45AM
10:00AM
07:00AM
May-21-24 11:46AM
09:35AM
May-20-24 10:27AM
May-17-24 11:41AM
May-16-24 04:17PM
12:45PM
May-14-24 02:11PM
06:21AM
May-13-24 06:46AM
May-10-24 04:25PM
May-09-24 04:47PM
03:53PM
05:44AM
May-08-24 02:17PM
(Investor's Business Daily)
12:15PM
12:28AM
May-07-24 02:50PM
May-06-24 11:45AM
10:51AM
07:44AM
May-03-24 04:07PM
11:02AM
09:40AM
May-01-24 01:41PM
(Investor's Business Daily)
12:09PM
Apr-30-24 12:45PM
09:50AM
08:29AM
08:10AM
06:10AM
Apr-29-24 01:10PM
12:28PM
09:39AM
09:35AM
09:24AM
09:15AM
08:25AM
08:25AM
07:57AM
07:16AM
06:54AM
06:46AM
Apr-28-24 06:54PM
06:49PM
Apr-27-24 01:01AM
Apr-26-24 10:39PM
(Thomson Reuters StreetEvents)
03:00PM
11:53AM
11:46AM
11:08AM
10:33AM
09:32AM
09:30AM
07:42AM
07:25AM
07:04AM
07:02AM
(Associated Press Finance)
07:00AM
06:55AM
06:00AM
Apr-25-24 03:00AM
Apr-24-24 03:02AM
Apr-23-24 02:32PM
12:25PM
09:15AM
07:30AM
Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Daniels Jennifer CLO and Secretary May 14 '24 Option Exercise 72.29 22,250 1,608,453 81,948 May 16 04:14 PM Daniels Jennifer CLO and Secretary May 14 '24 Sale 94.15 22,250 2,094,940 59,698 May 16 04:14 PM Massey Sally Chief Human Resources Officer May 09 '24 Option Exercise 72.29 12,226 883,818 26,150 May 10 04:17 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts May 09 '24 Option Exercise 72.29 12,000 867,480 17,118 May 10 04:16 PM Massey Sally Chief Human Resources Officer May 09 '24 Sale 94.06 12,226 1,149,926 13,924 May 10 04:17 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts May 09 '24 Sale 94.15 12,000 1,129,854 5,118 May 10 04:16 PM Kooyman John W Chief of Staff May 07 '24 Sale 93.47 3,497 326,882 3,181 May 09 04:07 PM Massey Sally Chief Human Resources Officer May 01 '24 Option Exercise 72.29 6,115 442,053 20,039 May 03 04:04 PM BILBREY JOHN P Director May 01 '24 Option Exercise 62.04 6,329 392,651 36,565 May 03 04:04 PM BILBREY JOHN P Director May 01 '24 Sale 91.59 6,329 579,696 30,236 May 03 04:04 PM Massey Sally Chief Human Resources Officer May 01 '24 Sale 91.92 6,115 562,091 13,924 May 03 04:04 PM Wallace Noel R. Chairman, President & CEO Feb 20 '24 Option Exercise 68.16 55,486 3,781,926 356,829 Feb 20 05:05 PM Wallace Noel R. Chairman, President & CEO Feb 20 '24 Sale 84.22 69,948 5,890,887 286,881 Feb 20 05:05 PM Daniels Jennifer CLO and Secretary Feb 20 '24 Sale 84.67 3,538 299,578 59,698 Feb 20 05:05 PM Parameswaran Prabha Grp Pres, Growth & Strategy Feb 16 '24 Option Exercise 68.16 56,836 3,873,942 75,517 Feb 20 04:22 PM Parameswaran Prabha Grp Pres, Growth & Strategy Feb 16 '24 Sale 84.02 56,836 4,775,378 18,681 Feb 20 04:22 PM Wallace Noel R. Chairman, President & CEO Feb 16 '24 Sale 84.06 29,772 2,502,664 301,343 Feb 20 05:05 PM Daniels Jennifer CLO and Secretary Feb 16 '24 Sale 83.96 5,790 486,108 63,236 Feb 20 05:05 PM Edwards Lisa Director Feb 13 '24 Option Exercise 69.38 2,078 144,172 11,805 Feb 15 04:09 PM Wallace Noel R. Chairman, President & CEO Feb 12 '24 Option Exercise 68.16 50,000 3,408,000 324,179 Feb 14 04:11 PM Wallace Noel R. Chairman, President & CEO Feb 12 '24 Sale 83.15 50,000 4,157,280 274,179 Feb 14 04:11 PM Kooyman John W Chief of Staff Feb 09 '24 Option Exercise 68.16 21,023 1,432,928 26,305 Feb 13 04:11 PM Kooyman John W Chief of Staff Feb 09 '24 Sale 83.60 21,023 1,757,458 5,282 Feb 13 04:11 PM Daniels Jennifer CLO and Secretary Feb 01 '24 Option Exercise 68.16 61,633 4,200,905 119,581 Feb 02 04:10 PM Malcolm Gregory EVP and Controller Feb 01 '24 Option Exercise 68.16 9,821 669,399 16,973 Feb 02 04:09 PM Daniels Jennifer CLO and Secretary Feb 01 '24 Sale 83.93 61,633 5,172,697 57,948 Feb 02 04:10 PM Malcolm Gregory EVP and Controller Feb 01 '24 Sale 85.35 8,930 762,184 8,043 Feb 02 04:09 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts Jan 31 '24 Option Exercise 68.16 30,433 2,074,313 42,559 Feb 02 04:09 PM HARRIS C MARTIN Director Jan 31 '24 Option Exercise 62.04 2,760 171,230 22,032 Feb 02 04:09 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts Jan 31 '24 Sale 84.41 30,433 2,568,706 12,126 Feb 02 04:09 PM HARRIS C MARTIN Director Jan 31 '24 Sale 84.50 2,760 233,220 19,272 Feb 02 04:09 PM Daniels Jennifer CLO and Secretary Nov 30 '23 Option Exercise 68.16 3,800 259,008 61,993 Dec 04 04:14 PM Daniels Jennifer CLO and Secretary Nov 30 '23 Sale 79.01 3,800 300,219 58,193 Dec 04 04:14 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts Nov 28 '23 Option Exercise 68.16 15,000 1,022,400 27,371 Nov 30 04:29 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts Nov 28 '23 Sale 77.83 15,000 1,167,410 12,371 Nov 30 04:29 PM CAHILL JOHN T Director Nov 03 '23 Option Exercise 62.04 6,329 392,651 31,015 Nov 07 04:15 PM CAHILL JOHN T Director Nov 03 '23 Sale 74.92 6,329 474,170 24,686 Nov 07 04:15 PM Kooyman John W Chief of Staff Nov 03 '23 Sale 75.11 3,000 225,330 5,347 Nov 07 04:14 PM NORRINGTON LORRIE M Director Nov 02 '23 Option Exercise 62.04 6,329 392,651 37,636 Nov 06 04:22 PM NORRINGTON LORRIE M Director Nov 02 '23 Sale 74.56 6,329 471,919 31,307 Nov 06 04:22 PM Wallace Noel R. Chairman, President & CEO Sep 11 '23 Option Exercise 73.00 48,627 3,549,771 295,596 Sep 13 04:04 PM Daniels Jennifer CLO and Secretary Sep 11 '23 Option Exercise 73.00 24,704 1,803,392 77,517 Sep 13 04:05 PM Wallace Noel R. Chairman, President & CEO Sep 11 '23 Sale 73.37 48,627 3,567,982 246,969 Sep 13 04:04 PM Daniels Jennifer CLO and Secretary Sep 11 '23 Sale 73.31 24,704 1,811,016 52,813 Sep 13 04:05 PM Malcolm Gregory Vice President and Controller Aug 31 '23 Option Exercise 73.00 10,493 765,989 18,345 Sep 01 04:03 PM Malcolm Gregory Vice President and Controller Aug 31 '23 Sale 73.90 10,493 775,457 7,852 Sep 01 04:03 PM Malcolm Gregory Vice President and Controller Aug 30 '23 Sale 73.85 1,365 100,805 7,852 Sep 01 04:03 PM Kooyman John W Chief of Staff Aug 02 '23 Option Exercise 73.00 21,677 1,582,421 28,061 Aug 04 04:05 PM Kooyman John W Chief of Staff Aug 02 '23 Sale 77.69 21,677 1,684,062 6,384 Aug 04 04:05 PM
Index -
P/E -
EPS (ttm) -2.64
Insider Own 1.17%
Shs Outstand 492.85M
Perf Week -0.99%
Market Cap 8.91B
Forward P/E 16.87
EPS next Y 1.07
Insider Trans 0.93%
Shs Float 488.40M
Perf Month 5.81%
Income -1302.00M
PEG -
EPS next Q 0.24
Inst Own 97.98%
Short Float 3.38%
Perf Quarter 14.69%
Sales 4.37B
P/S 2.04
EPS this Y 5.76%
Inst Trans -3.01%
Short Ratio 3.91
Perf Half Y 31.99%
Book/sh 12.26
P/B 1.47
EPS next Y 13.56%
ROA -8.74%
Short Interest 16.51M
Perf Year 83.05%
Cash/sh 0.70
P/C 25.83
EPS next 5Y 8.93%
ROE -19.24%
52W Range 8.52 - 18.80
Perf YTD 21.01%
Dividend Est. -
P/FCF 32.52
EPS past 5Y -
ROI -11.05%
52W High -4.10%
Beta 1.45
Dividend TTM -
Quick Ratio 1.96
Sales past 5Y 9.00%
Gross Margin 42.75%
52W Low 111.62%
ATR (14) 0.49
Dividend Ex-Date -
Current Ratio 3.29
EPS Y/Y TTM -5619.91%
Oper. Margin 5.45%
RSI (14) 62.95
Volatility 2.84% 2.62%
Employees 9800
Debt/Eq 0.95
Sales Y/Y TTM -1.91%
Profit Margin -29.83%
Recom 2.07
Target Price 19.09
Option/Short Yes / Yes
LT Debt/Eq 0.95
EPS Q/Q -69.14%
Payout -
Rel Volume 0.53
Prev Close 18.11
Sales Surprise 1.45%
EPS Surprise 24.09%
Sales Q/Q -4.14%
Earnings May 08 BMO
Avg Volume 4.23M
Price 18.03
SMA20 2.63%
SMA50 14.65%
SMA200 30.15%
Trades
Volume 2,257,753
Change -0.44%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-05-24 Upgrade
Stifel
Hold → Buy
$13 → $20
Dec-19-23 Initiated
Jefferies
Buy
$17
Dec-15-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$16
Dec-07-23 Initiated
Exane BNP Paribas
Outperform
$18
Apr-20-23 Upgrade
Barclays
Equal Weight → Overweight
$14
Aug-18-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$37 → $22
Aug-16-22 Downgrade
JP Morgan
Overweight → Neutral
$28 → $24
Jul-21-22 Downgrade
Goldman
Buy → Sell
$32 → $19
Jul-12-22 Initiated
Piper Sandler
Neutral
$22
Nov-18-21 Initiated
Morgan Stanley
Overweight
$40
Oct-28-21 Downgrade
Stifel
Buy → Hold
$37 → $34
Aug-05-21 Resumed
Credit Suisse
Outperform
$38
Jun-15-21 Upgrade
Cleveland Research
Underperform → Neutral
May-11-21 Upgrade
Gabelli & Co
Hold → Buy
May-11-21 Upgrade
Barclays
Underweight → Equal Weight
$25 → $29
Apr-15-21 Initiated
Stifel
Buy
$37
Mar-22-21 Downgrade
Gabelli & Co
Buy → Hold
Feb-26-21 Upgrade
Credit Suisse
Neutral → Outperform
$33 → $38
Dec-09-20 Downgrade
Argus
Buy → Hold
Nov-09-20 Downgrade
Barclays
Overweight → Underweight
$35 → $25
Show Previous Ratings
Jun-07-24 12:00PM
Jun-06-24 08:00AM
May-28-24 07:30PM
06:27AM
May-24-24 02:39AM
04:03PM
Loading…
May-23-24 04:03PM
May-21-24 08:00AM
May-13-24 09:17AM
May-09-24 08:54PM
11:33AM
10:26AM
09:44AM
07:43AM
(The Wall Street Journal)
03:05AM
May-08-24 04:04PM
(Investor's Business Daily) +24.93%
02:00PM
Loading…
02:00PM
12:32PM
09:30AM
09:18AM
07:52AM
07:25AM
06:28AM
May-06-24 09:15AM
Apr-25-24 11:27AM
Apr-23-24 08:30AM
Apr-21-24 10:39AM
Apr-17-24 08:00AM
Apr-01-24 07:00AM
06:39AM
06:30AM
11:37PM
Loading…
Mar-31-24 11:37PM
Mar-13-24 02:21PM
Mar-12-24 07:00PM
Mar-05-24 10:15AM
Mar-04-24 08:33AM
Feb-29-24 03:30PM
01:08PM
08:00AM
07:03AM
Feb-28-24 10:58AM
Feb-26-24 11:41PM
(Thomson Reuters StreetEvents)
02:15PM
09:30AM
06:52AM
06:27AM
Feb-22-24 08:00AM
Feb-21-24 09:15AM
Feb-19-24 10:00AM
Feb-15-24 07:00AM
Feb-13-24 01:09PM
Feb-09-24 10:15AM
Feb-08-24 02:46PM
08:00AM
Feb-07-24 01:25PM
Feb-05-24 07:01AM
(The Wall Street Journal) +7.94%
06:48AM
06:36AM
06:33AM
06:33AM
Jan-18-24 08:22PM
Jan-17-24 08:30AM
Jan-08-24 07:35AM
Jan-02-24 08:33AM
Jan-01-24 09:15AM
Dec-19-23 08:00AM
Dec-14-23 05:08PM
Dec-08-23 09:00AM
Dec-07-23 04:37PM
Nov-27-23 08:00AM
Nov-10-23 05:20PM
Nov-09-23 03:49AM
Nov-08-23 04:03PM
12:21AM
(Thomson Reuters StreetEvents)
Nov-07-23 01:45PM
09:30AM
07:31AM
07:03AM
06:33AM
Nov-02-23 11:33AM
08:00AM
07:16AM
Nov-01-23 09:00AM
Oct-30-23 04:32PM
Oct-17-23 04:57PM
08:00AM
Oct-09-23 09:55AM
Oct-06-23 12:05PM
08:36AM
Oct-05-23 11:22AM
Oct-04-23 06:30AM
Sep-19-23 06:20AM
04:23AM
Sep-12-23 06:40AM
Sep-07-23 04:15PM
Sep-05-23 05:00PM
Aug-09-23 10:36AM
07:56AM
Aug-08-23 12:16AM
(Thomson Reuters StreetEvents)
Aug-07-23 02:30PM
12:34PM
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
DOYLE WILLIAM F Director May 21 '24 Buy 16.98 15,000 254,700 76,330 May 23 04:33 PM DOYLE WILLIAM F Director Mar 08 '24 Buy 16.30 15,000 244,500 61,330 Mar 12 04:32 PM Harrington Michael J Director Mar 08 '24 Buy 16.29 3,100 50,494 77,594 Mar 12 04:30 PM HOOVER R DAVID Director Mar 06 '24 Buy 16.14 20,000 322,808 185,000 Mar 08 05:09 PM
Index S&P 500
P/E 11.07
EPS (ttm) 3.78
Insider Own 0.38%
Shs Outstand 229.77M
Perf Week -3.62%
Market Cap 9.61B
Forward P/E 9.20
EPS next Y 4.55
Insider Trans -0.29%
Shs Float 228.81M
Perf Month -2.02%
Income 880.80M
PEG 1.01
EPS next Q 0.89
Inst Own 93.40%
Short Float 2.50%
Perf Quarter -10.74%
Sales 6.70B
P/S 1.43
EPS this Y 9.44%
Inst Trans 3.71%
Short Ratio 1.62
Perf Half Y 21.08%
Book/sh 12.08
P/B 3.46
EPS next Y 7.07%
ROA 8.51%
Short Interest 5.72M
Perf Year -4.24%
Cash/sh 32.28
P/C 1.30
EPS next 5Y 11.00%
ROE 34.96%
52W Range 25.99 - 48.80
Perf YTD 13.58%
Dividend Est. 1.38 (3.30%)
P/FCF 7.37
EPS past 5Y 23.01%
ROI 7.52%
52W High -14.32%
Beta 1.62
Dividend TTM 1.40 (3.35%)
Quick Ratio 5.98
Sales past 5Y 3.32%
Gross Margin 72.49%
52W Low 60.87%
ATR (14) 1.06
Dividend Ex-Date Jun 07, 2024
Current Ratio 6.59
EPS Y/Y TTM 2.54%
Oper. Margin 21.10%
RSI (14) 45.95
Volatility 2.63% 2.23%
Employees 18500
Debt/Eq 3.34
Sales Y/Y TTM 0.50%
Profit Margin 13.15%
Recom 1.79
Target Price 49.58
Option/Short Yes / Yes
LT Debt/Eq 3.22
EPS Q/Q -23.58%
Payout 30.94%
Rel Volume 0.45
Prev Close 42.36
Sales Surprise -1.11%
EPS Surprise 18.59%
Sales Q/Q -1.80%
Earnings May 09 BMO
Avg Volume 3.53M
Price 41.81
SMA20 -2.05%
SMA50 0.75%
SMA200 11.78%
Trades
Volume 1,600,261
Change -1.30%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-24 Reiterated
Telsey Advisory Group
Outperform
$49 → $54
Feb-29-24 Downgrade
Jefferies
Buy → Hold
$50
Feb-05-24 Upgrade
Evercore ISI
In-line → Outperform
$30 → $50
Dec-12-23 Resumed
Morgan Stanley
Equal-Weight
$38
Nov-07-23 Initiated
Evercore ISI
In-line
$30
Sep-13-23 Downgrade
Redburn Atlantic
Overweight → Neutral
$33
Aug-01-23 Upgrade
Barclays
Equal Weight → Overweight
$47 → $59
May-15-23 Upgrade
Bernstein
Mkt Perform → Outperform
$50 → $55
Jan-23-23 Downgrade
Barclays
Overweight → Equal Weight
$43
Jan-05-23 Downgrade
Bernstein
Outperform → Mkt Perform
Dec-20-22 Initiated
Raymond James
Outperform
$44
Dec-12-22 Upgrade
Goldman
Neutral → Buy
$37 → $44
Jun-15-22 Upgrade
Jefferies
Hold → Buy
$30 → $45
Mar-15-22 Initiated
Bernstein
Outperform
$62
Jan-28-22 Upgrade
Citigroup
Neutral → Buy
$50 → $48
Nov-19-21 Upgrade
Argus
Hold → Buy
$54
Jul-14-21 Initiated
Goldman
Neutral
$42
May-07-21 Upgrade
BTIG Research
Neutral → Buy
$65
Feb-22-21 Upgrade
Credit Suisse
Neutral → Outperform
$39 → $50
Feb-09-21 Upgrade
Telsey Advisory Group
Market Perform → Outperform
$38 → $46
Show Previous Ratings
Jun-13-24 09:45AM
Jun-12-24 08:12PM
Jun-10-24 02:45PM
Jun-05-24 11:53AM
Jun-03-24 03:38PM
(Investor's Business Daily)
06:00AM
Loading…
06:00AM
May-31-24 09:00AM
08:00AM
May-30-24 02:30PM
May-29-24 06:26PM
08:45AM
May-28-24 09:30AM
May-25-24 05:22PM
May-24-24 07:15AM
07:00AM
(The Wall Street Journal)
12:05AM
Loading…
May-23-24 12:05AM
May-21-24 12:01AM
May-20-24 12:07PM
May-16-24 02:15PM
01:11PM
10:44AM
10:44AM
07:01AM
May-13-24 05:48PM
02:30PM
11:05AM
12:01AM
May-10-24 01:38PM
12:31PM
12:02PM
09:02AM
Loading…
09:02AM
08:54AM
07:11AM
06:22AM
May-09-24 10:20PM
(Thomson Reuters StreetEvents)
05:21PM
02:36PM
11:00AM
10:53AM
09:30AM
08:36AM
08:21AM
08:20AM
07:55AM
06:58AM
(Associated Press Finance)
06:51AM
06:49AM
06:47AM
06:45AM
May-08-24 02:08PM
03:06AM
May-07-24 03:15PM
08:00AM
May-06-24 11:45AM
09:16AM
May-05-24 10:18AM
May-02-24 10:01AM
08:45AM
07:00AM
Apr-30-24 02:37PM
10:54AM
08:45AM
Apr-29-24 12:01AM
Apr-26-24 08:45AM
Apr-25-24 06:45AM
02:00AM
Apr-24-24 01:58PM
Apr-23-24 05:55PM
05:18PM
12:59PM
11:53AM
(The Wall Street Journal)
11:53AM
(The Wall Street Journal)
10:31AM
(The Wall Street Journal)
09:05AM
08:55AM
06:29AM
Apr-22-24 06:21PM
(Associated Press Finance)
05:46PM
(The Wall Street Journal)
05:38PM
05:29PM
05:12PM
(The Wall Street Journal)
05:10PM
04:59PM
12:02PM
Apr-20-24 07:00AM
(The Wall Street Journal)
Apr-19-24 09:00AM
Apr-17-24 07:47PM
07:44AM
Apr-16-24 05:48AM
Apr-15-24 12:29PM
12:04PM
10:58AM
Apr-12-24 10:45AM
Apr-09-24 04:32PM
Apr-05-24 09:40AM
Apr-04-24 03:33PM
08:00AM
Apr-03-24 06:43PM
01:33PM
11:42AM
Tapestry, Inc. engages in the provision of luxury accessories and lifestyle brands. It operates through the following segments: Coach, Kate Spade, and Stuart Weitzman. The Coach segment consists of global sales of Coach brand products to customers through Coach operated stores, including the internet and concession shop-in-shops, and sales to wholesale customers, and through independent third-party distributors. The Kate Spade segment focuses on Kate Spade New York brand products to customers through Kate Spade operated stores, including the Internet, sales to wholesale customers, through concession shop-in-shops and through independent third-party distributors. The Stuart Weitzman segment includes Stuart Weitzman brand products primarily through Stuart Weitzman operated stores. The company was founded by Dawn Hughes in 1941 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Dadlani Manesh VP, Controller and PAO May 24 '24 Sale 42.23 2,500 105,575 37,173 May 29 06:23 PM
Index -
P/E 24.93
EPS (ttm) 0.07
Insider Own 80.39%
Shs Outstand 660.73M
Perf Week 2.29%
Market Cap 1.18B
Forward P/E 10.49
EPS next Y 0.17
Insider Trans -0.01%
Shs Float 129.76M
Perf Month 11.87%
Income 48.37M
PEG 4.09
EPS next Q 0.03
Inst Own 18.12%
Short Float 6.49%
Perf Quarter -4.79%
Sales 443.42M
P/S 2.67
EPS this Y -10.53%
Inst Trans -1.58%
Short Ratio 4.19
Perf Half Y -27.82%
Book/sh 1.29
P/B 1.38
EPS next Y 19.17%
ROA 2.78%
Short Interest 8.43M
Perf Year -50.14%
Cash/sh 0.77
P/C 2.33
EPS next 5Y 6.10%
ROE 5.82%
52W Range 1.19 - 4.26
Perf YTD -29.53%
Dividend Est. -
P/FCF 6.87
EPS past 5Y -0.81%
ROI 3.22%
52W High -58.03%
Beta 2.45
Dividend TTM -
Quick Ratio 9.12
Sales past 5Y 46.30%
Gross Margin 60.15%
52W Low 50.42%
ATR (14) 0.13
Dividend Ex-Date -
Current Ratio 10.71
EPS Y/Y TTM -76.43%
Oper. Margin 20.81%
RSI (14) 55.70
Volatility 9.18% 7.33%
Employees 233
Debt/Eq 0.76
Sales Y/Y TTM -29.82%
Profit Margin 10.91%
Recom 3.00
Target Price 2.36
Option/Short Yes / Yes
LT Debt/Eq 0.76
EPS Q/Q -61.89%
Payout 0.00%
Rel Volume 0.88
Prev Close 1.85
Sales Surprise 3.95%
EPS Surprise 7.53%
Sales Q/Q -13.08%
Earnings May 02 BMO
Avg Volume 2.01M
Price 1.79
SMA20 6.09%
SMA50 14.46%
SMA200 -7.85%
Trades
Volume 1,775,004
Change -3.24%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-19-24 Upgrade
Piper Sandler
Underweight → Neutral
$1.25 → $2
Oct-04-23 Upgrade
Barclays
Underweight → Equal Weight
Aug-25-23 Downgrade
Piper Sandler
Neutral → Underweight
$3 → $2
Aug-11-23 Downgrade
Canaccord Genuity
Buy → Hold
$5 → $3
Aug-09-23 Downgrade
Telsey Advisory Group
Outperform → Market Perform
$6 → $4
Mar-16-23 Downgrade
TD Cowen
Outperform → Market Perform
$10 → $4.50
Mar-01-23 Downgrade
Goldman
Buy → Neutral
$6
Nov-17-22 Initiated
Canaccord Genuity
Buy
$8
Oct-19-22 Downgrade
Raymond James
Strong Buy → Mkt Perform
Oct-19-22 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$13 → $6.50
Oct-19-22 Downgrade
JP Morgan
Overweight → Underweight
$16 → $8
Oct-19-22 Downgrade
Jefferies
Buy → Hold
$18 → $6
Oct-19-22 Downgrade
Evercore ISI
Outperform → In-line
$40 → $10
Oct-19-22 Downgrade
BofA Securities
Buy → Underperform
$15 → $5
Oct-19-22 Downgrade
Barclays
Equal Weight → Underweight
$5
Sep-29-22 Downgrade
Piper Sandler
Overweight → Neutral
$19 → $12
Aug-03-22 Downgrade
Barclays
Overweight → Equal Weight
$16
Mar-09-22 Upgrade
Barclays
Equal Weight → Overweight
$29 → $17
Feb-23-22 Upgrade
Jefferies
Hold → Buy
$25
Nov-08-21 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$31
Show Previous Ratings
May-24-24 06:55AM
May-06-24 10:52AM
May-03-24 09:30AM
03:34AM
May-02-24 10:53AM
09:52AM
Loading…
09:52AM
09:30AM
07:30AM
06:48AM
06:45AM
May-01-24 03:15AM
Apr-25-24 10:02AM
Apr-18-24 07:45AM
Apr-05-24 11:59AM
Apr-04-24 05:20PM
01:57PM
Loading…
Mar-25-24 01:57PM
Mar-01-24 09:57AM
01:40AM
(Thomson Reuters StreetEvents)
Feb-29-24 12:28PM
12:14PM
09:30AM
08:53AM
07:55AM
07:00AM
06:45AM
Feb-28-24 02:02AM
Feb-27-24 06:45AM
Feb-26-24 09:16AM
Feb-22-24 10:00AM
Feb-15-24 06:45AM
09:21AM
Loading…
Feb-06-24 09:21AM
Jan-29-24 04:53AM
Jan-26-24 02:22AM
Jan-25-24 03:37AM
Jan-24-24 05:37AM
Jan-23-24 05:23AM
Jan-22-24 04:12AM
Jan-16-24 02:39AM
Jan-11-24 04:30AM
Jan-10-24 07:44AM
Dec-30-23 08:49AM
Dec-06-23 11:55AM
Nov-22-23 06:45AM
Nov-08-23 04:57PM
Nov-07-23 09:36AM
09:30AM
06:45AM
06:32AM
Oct-31-23 10:01AM
Oct-24-23 06:45AM
Oct-12-23 08:00AM
Oct-05-23 02:30AM
Sep-06-23 08:30AM
Aug-28-23 09:07AM
Aug-25-23 09:42AM
Aug-24-23 06:45AM
Aug-11-23 09:55AM
Aug-09-23 12:11AM
(Thomson Reuters StreetEvents) -13.31%
Aug-08-23 12:33PM
10:32AM
10:00AM
09:51AM
08:05AM
06:45AM
Jul-31-23 11:58PM
Jul-25-23 06:45AM
Jul-11-23 08:00AM
Jun-28-23 07:00AM
Jun-16-23 08:21AM
Jun-12-23 07:11AM
May-25-23 08:01AM
May-22-23 08:11AM
May-21-23 07:45AM
May-15-23 08:30AM
May-10-23 01:46AM
(Thomson Reuters StreetEvents)
May-09-23 08:05AM
06:45AM
May-08-23 06:45AM
May-05-23 02:24PM
08:31AM
Apr-28-23 02:34AM
Apr-25-23 04:05PM
Apr-16-23 09:15AM
Apr-12-23 08:32AM
Apr-06-23 12:04PM
(The Wall Street Journal)
Mar-31-23 07:05AM
05:19AM
Mar-29-23 07:33AM
Mar-23-23 06:40AM
Mar-09-23 09:19AM
Mar-02-23 03:18PM
05:19AM
Mar-01-23 02:26AM
(Thomson Reuters StreetEvents) -6.91%
Feb-28-23 12:59PM
10:43AM
09:52AM
09:16AM
08:17AM
08:05AM
06:45AM
Olaplex Holdings, Inc. is a science-enabled, technology-driven beauty company, focused on delivering its patent-protected hair care products to professional hair salons, retailers, and everyday consumers. The brand OLAPLEX is a patent-protected, proven, and potent haircare technology system that restores all hair types to its healthiest state possible. OLAPLEX created the Bond Building category which protects, strengthens, and rebuilds broken bonds in the hair during and after hair services. The company was founded in 2014 and is headquartered in Santa Barbara, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Belhumeur Kristi A Senior VP of Accounting May 03 '24 Sale 1.68 42,480 71,366 294,553 May 07 04:18 PM BILBREY JOHN P Director Sep 15 '23 Buy 2.29 8,100 18,549 58,100 Sep 18 05:16 PM BILBREY JOHN P Director Aug 15 '23 Buy 2.63 43,500 114,405 50,000 Aug 15 04:10 PM BILBREY JOHN P Director Aug 14 '23 Buy 2.65 6,500 17,225 6,500 Aug 15 04:10 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite